M

MIRA Pharmaceuticals
D

MIRA

1.01000
USD
-0.01
(-0.98%)
مغلق
حجم التداول
576
الربح لكل سهم
-0
العائد الربحي
-
P/E
-1
حجم السوق
42,442,308
المقالات
المزيد

العنوان: MIRA Pharmaceuticals

القطاع: Healthcare
الصناعة: Drug Manufacturers - General
Mira Pharmaceuticals Inc is a clinical-stage pharmaceutical development company focused on developing novel oral small-molecule therapeutics for neurologic, neuropsychiatric, metabolic, and inflammatory disorders. The company's pipeline includes three product candidates: Ketamir-2, MIRA-55, and SKNY-1, three drug candidates designed to address unmet medical needs across neuropathic and inflammatory pain, central nervous system disorders, and metabolic and behavioral conditions. The company operates as a single operating and reportable segment.